Investing Ideas
/
Swiss Undervalued Stocks Based On Cash Flows

Swiss Undervalued Stocks Based On Cash Flows

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

1 new

Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.

12 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
GALD Galderma Group	CHF 113.76	-0.3%	n/a	CHF 27.0b	CHF 107.26	PS7x	E36.6%	n/a	Pharmaceuticals & Biotech
KOMN Komax Holding	CHF 126.40	-4.2%	-20.4%	CHF 646.9m	CHF 175.00	PE113.6x	E90.7%	2.4%	Capital Goods
SRAIL Stadler Rail	CHF 20.80	-1.0%	-27.7%	CHF 2.1b	CHF 20.60	PE17x	E22.9%	4.3%	Capital Goods
DAE New Dätwyler Holding	CHF 132.00	-6.8%	-30.1%	CHF 2.2b	CHF 152.40	PE72.2x	E35.0%	2.4%	Capital Goods
CLTN COLTENE Holding	CHF 54.00	0%	-5.3%	CHF 322.7m	CHF 62.50	PE26.1x	E22.9%	3.7%	Healthcare
COTN Comet Holding	CHF 276.00	0.2%	-10.5%	CHF 2.1b	CHF 356.86	PE122.5x	E48.6%	0.4%	Tech
STGN StarragTornos Group	CHF 37.40	3.9%	-18.0%	CHF 203.3m	CHF 53.67	PE11.2x	E27.1%	6.7%	Capital Goods
CICN Cicor Technologies	CHF 69.80	2.3%	39.0%	CHF 298.2m	CHF 82.98	PE29.1x	E28.8%	0%	Tech
YPSN Ypsomed Holding	CHF 363.00	-3.7%	2.0%	CHF 5.0b	CHF 444.20	PE66.6x	E42.0%	0.6%	Healthcare
ACLN Accelleron Industries	CHF 42.58	-1.7%	44.0%	CHF 4.0b	CHF 49.65	PE31.1x	E13.5%	2.0%	Capital Goods
SKAN SKAN Group	CHF 77.60	1.3%	-5.3%	CHF 1.7b	CHF 90.67	PE54.1x	E17.9%	0.5%	Pharmaceuticals & Biotech
KUD Kudelski	CHF 1.46	0.7%	7.0%	CHF 81.9m	CHF 1.51	PS0.1x	E103.4%	0%	Tech

Page 1 of 1